Literature DB >> 9536888

Systemic and local immunological features of atopic dermatitis patients with ocular complications.

E Uchio1, K Miyakawa, Z Ikezawa, S Ohno.   

Abstract

AIMS: Clinical factors and data from recent cases of atopic dermatitis (AD) (with or without ocular complications) and non-AD cases were examined to evaluate the mechanism of atopic ocular complications.
METHODS: IgE-RAST for eight allergens including rice, egg, and mite and serum total IgE were measured in 216 patients with AD (70 ocular type, 146 non-ocular type) and 69 non-AD individuals. Tear histamine and leukotriene B4 (LTB4) levels were also measured.
RESULTS: The serum levels of IgE were significantly increased in AD patients with ocular complications compared with those without ocular complications. The positive rates of IgE-RAST for rice and wheat were significantly higher in ocular type AD than in non-ocular type AD. In ocular type AD, serum IgE was significantly increased in patients with cataract compared with that in those without cataract. Tear histamine and LTB4 levels in AD patients with ocular complications showed significant elevations compared with those in patients with pure AD and controls.
CONCLUSIONS: These results suggest that ocular type AD belongs to the most severe end of the spectrum of AD, and that some food antigens may contribute to the pathogenesis of severe AD resulting in ocular complications.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9536888      PMCID: PMC1722359          DOI: 10.1136/bjo.82.1.82

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Occurrence of cataracts and keratoconus with atopic dermatitis.

Authors:  L A BRUNSTING; W B REED; H L BAIR
Journal:  AMA Arch Derm       Date:  1955-09

2.  Atopic keratoconjunctivitis.

Authors:  M J HOGAN
Journal:  Am J Ophthalmol       Date:  1953-07       Impact factor: 5.258

3.  The alpha and gamma crystallin content in aqueous humor of eyes with clear lenses and with cataracts.

Authors:  H O Sandberg; O Closs
Journal:  Exp Eye Res       Date:  1979-05       Impact factor: 3.467

Review 4.  Functional aspects of helper T cell clones.

Authors:  M H Schreier; R Tees; A A Nordin; R Benner; A T Bianchi; M J van Zwieten
Journal:  Immunobiology       Date:  1982-03       Impact factor: 3.144

Review 5.  Atopic dermatitis.

Authors:  J M Hanifin
Journal:  J Allergy Clin Immunol       Date:  1984-02       Impact factor: 10.793

6.  Serum IgE and IgE antibody levels in patients with bronchial asthma, atopic dermatitis, eosinophilic granulomas of the soft tissue (Kimura's disease) and other diseases.

Authors:  H Okudaira; O Hongo; T Ogita; M Haida; N Yamauchi; T Miyamoto
Journal:  Ann Allergy       Date:  1983-01

7.  Food hypersensitivity and atopic dermatitis: evaluation of 113 patients.

Authors:  H A Sampson; C C McCaskill
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

8.  Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin.

Authors:  H Nathan; N Naveh; E Meyer
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

9.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses.

Authors:  F D Finkelman; I M Katona; T R Mosmann; R L Coffman
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

View more
  9 in total

Review 1.  [Skin and eyes].

Authors:  E Kohl; J Hillenkamp; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

2.  Generation of transgenic rice with reduced content of major and novel high molecular weight allergens.

Authors:  Yuko Ogo; Yuhya Wakasa; Kana Hirano; Atsuo Urisu; Tsukasa Matsuda; Fumio Takaiwa
Journal:  Rice (N Y)       Date:  2014-08-29       Impact factor: 4.783

3.  Protective effects of Cassia tora leaves in experimental cataract by modulating intracellular communication, membrane co-transporters, energy metabolism and the ubiquitin-proteasome pathway.

Authors:  V Sreelakshmi; Annie Abraham
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 4.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

Review 5.  A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.

Authors:  Gaurav Agnihotri; Katherine Shi; Peter A Lio
Journal:  Drugs R D       Date:  2019-12

6.  Conjunctivitis in dupilumab clinical trials.

Authors:  B Akinlade; E Guttman-Yassky; M de Bruin-Weller; E L Simpson; A Blauvelt; M J Cork; E Prens; P Asbell; E Akpek; J Corren; C Bachert; I Hirano; J Weyne; A Korotzer; Z Chen; T Hultsch; X Zhu; J D Davis; L Mannent; J D Hamilton; A Teper; H Staudinger; E Rizova; G Pirozzi; N M H Graham; B Shumel; M Ardeleanu; A Wollenberg
Journal:  Br J Dermatol       Date:  2019-05-07       Impact factor: 9.302

7.  Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.

Authors:  Ashish Bansal; Eric L Simpson; Amy S Paller; Elaine C Siegfried; Andrew Blauvelt; Marjolein de Bruin-Weller; Jonathan Corren; Lawrence Sher; Emma Guttman-Yassky; Zhen Chen; Nadia Daizadeh; Mohamed A Kamal; Brad Shumel; Paola Mina-Osorio; Leda Mannent; Naimish Patel; Neil M H Graham; Faisal A Khokhar; Marius Ardeleanu
Journal:  Am J Clin Dermatol       Date:  2021-01       Impact factor: 7.403

8.  Acute keratoconjunctivitis due to contamination of contact lens care solution with histamine-producing Raoultella species: A case report.

Authors:  Hiroshi Eguchi; Fumika Hotta; Tomomi Kuwahara; Haruyuki Nakayama-Imaohji; Shunji Kusaka; Yoshikazu Shimomura
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

9.  A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world.

Authors:  Dong Hyek Jang; Seok Jae Heo; Hyung Don Kook; Dong Heon Lee; Hye Jung Jung; Mi Yeon Park; Jiyoung Ahn
Journal:  Sci Rep       Date:  2021-12-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.